FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1283148 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
5-15 questionnaire Preferred (foundation metadata concept)
5-15 questionnaire (assessment scale) Preferred (foundation metadata concept)
5-ASA Acceptable (foundation metadata concept)
5-Aminolevulinate synthase Preferred (foundation metadata concept)
5-Aminolevulinate synthase (substance) Preferred (foundation metadata concept)
5-Chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one Kathon (3:1 in water) Preferred (foundation metadata concept)
5-Chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one Kathon (3:1 in water) (product) Preferred (foundation metadata concept)
5-Chloro-7-iodo-quinolinol Preferred (foundation metadata concept)
5-Chloro-7-iodo-quinolinol Preferred (foundation metadata concept)
5-Chloro-7-iodo-quinolinol (product) Preferred (foundation metadata concept)
5-Chloro-7-iodo-quinolinol (substance) Preferred (foundation metadata concept)
5-FC Acceptable (foundation metadata concept)
5-Fluorocytosine measurement Acceptable (foundation metadata concept)
5-HIAA - 5-Hydroxyindole acetic acid Acceptable (foundation metadata concept)
5-HIAA - 5-Hydroxyindole acetic acid Acceptable (foundation metadata concept)
5-HIAA - 5-Hydroxyindole acetic acid Acceptable (foundation metadata concept)
5-HIAA quantitative, urine Acceptable (foundation metadata concept)
5-HPETE Acceptable (foundation metadata concept)
5-HT - 5-hydroxytryptamine Acceptable (foundation metadata concept)
5-HT secreting neuroendocrine tumor Preferred (foundation metadata concept)
5-HT3 receptor antagonist Preferred (foundation metadata concept)
5-HT3 receptor antagonist Preferred (foundation metadata concept)
5-HT3 receptor antagonist-containing product Preferred (foundation metadata concept)
5-HT3-receptor antagonist adverse reaction Preferred (foundation metadata concept)
5-HT3-receptor antagonist allergy Acceptable (foundation metadata concept)
5-HT3-receptor antagonist overdose Preferred (foundation metadata concept)
5-HT3-receptor antagonist overdose of undetermined intent Preferred (foundation metadata concept)
5-HT3-receptor antagonist poisoning Preferred (foundation metadata concept)
5-HT3-receptor antagonist poisoning of undetermined intent Preferred (foundation metadata concept)
5-He Acceptable (foundation metadata concept)
5-Hydroxy-indoleacetic acid Preferred (foundation metadata concept)
5-Hydroxy-indoleacetic acid (substance) Preferred (foundation metadata concept)
5-Hydroxyhexanoate measurement Preferred (foundation metadata concept)
5-Hydroxyhexanoate measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid (substance) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement, quantitative, urine Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid measurement, quantitative, urine (procedure) Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid/creatinine ratio measurement Preferred (foundation metadata concept)
5-Hydroxyindoleacetic acid/creatinine ratio measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxytryptamine measurement Acceptable (foundation metadata concept)
5-Hydroxytryptamine release Acceptable (foundation metadata concept)
5-Hydroxytryptamine release measurement Preferred (foundation metadata concept)
5-Hydroxytryptamine release measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxytryptamine uptake Acceptable (foundation metadata concept)
5-Hydroxytryptamine uptake measurement Preferred (foundation metadata concept)
5-Hydroxytryptamine uptake measurement (procedure) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist adverse reaction Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist adverse reaction (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent (disorder) Preferred (foundation metadata concept)
5-Hydroxytryptophan measurement Preferred (foundation metadata concept)
5-Hydroxytryptophan measurement (procedure) Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase (substance) Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate/shikimate 3'-hydroxylase Acceptable (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) (procedure) Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) (procedure) Preferred (foundation metadata concept)
5-Oxoprolinase deficiency Preferred (foundation metadata concept)
5-Oxoprolinase deficiency (disorder) Preferred (foundation metadata concept)
5-Oxoproline Preferred (foundation metadata concept)
5-Oxoproline (substance) Preferred (foundation metadata concept)
5-Oxoproline + pipecolate Preferred (foundation metadata concept)
5-Oxoproline + pipecolate (substance) Preferred (foundation metadata concept)
5-Oxoproline measurement Preferred (foundation metadata concept)
5-Oxoproline measurement (procedure) Preferred (foundation metadata concept)
5-Oxoprolinuria Acceptable (foundation metadata concept)
5-WAY LEPTOSPIROSIS VACCINE Preferred (foundation metadata concept)
5-WAY LEPTOSPIROSIS VACCINE (product) Preferred (foundation metadata concept)
5-alpha reductase deficiency Acceptable (foundation metadata concept)
5-alpha reductase inhibitor Preferred (foundation metadata concept)
5-alpha reductase inhibitor Preferred (foundation metadata concept)
5-alpha reductase inhibitor (disposition) Preferred (foundation metadata concept)
5-alpha reductase inhibitor-containing product Preferred (foundation metadata concept)
5-alpha tetrahydro-11-dehydrocorticosterone Preferred (foundation metadata concept)
5-alpha tetrahydro-11-dehydrocorticosterone (substance) Preferred (foundation metadata concept)
5-alpha-Tetrahydrocortisol measurement Preferred (foundation metadata concept)
5-alpha-Tetrahydrocortisol measurement (procedure) Preferred (foundation metadata concept)
5-alpha-dihydrotestosterone Acceptable (foundation metadata concept)
5-alpha-tetrahydrocortisol Preferred (foundation metadata concept)
5-alpha-tetrahydrocortisol (substance) Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosiduria Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosiduria (disorder) Preferred (foundation metadata concept)
5-amino-6-(5-phosphoribosylamino) uracil reductase Preferred (foundation metadata concept)
5-amino-6-(5-phosphoribosylamino) uracil reductase (substance) Preferred (foundation metadata concept)
5-aminolevulinate Preferred (foundation metadata concept)
5-aminolevulinate (substance) Preferred (foundation metadata concept)
5-aminolevulinate dehydratase Acceptable (foundation metadata concept)
5-aminolevulinate synthase Preferred (foundation metadata concept)
5-aminolevulinate synthase (substance) Preferred (foundation metadata concept)
5-aminolevulinic acid Preferred (foundation metadata concept)

Start Previous Page 119 of 12832 Next End


Reference Sets

Reference set descriptor

Back to Start